XETRA - Delayed Quote EUR

Thermo Fisher Scientific Inc. (TN8.DE)

365.40
+6.20
+(1.73%)
At close: May 16 at 5:35:49 PM GMT+2
Loading Chart for TN8.DE
  • Previous Close 359.20
  • Open 362.60
  • Bid 364.90 x --
  • Ask 365.45 x --
  • Day's Range 359.95 - 365.95
  • 52 Week Range 350.00 - 590.90
  • Volume 331
  • Avg. Volume 276
  • Market Cap (intraday) 138.971B
  • Beta (5Y Monthly) 0.83
  • PE Ratio (TTM) 23.98
  • EPS (TTM) 15.24
  • Earnings Date Jul 22, 2025 - Jul 28, 2025
  • Forward Dividend & Yield 1.52 (0.42%)
  • Ex-Dividend Date Mar 14, 2025
  • 1y Target Est --

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment includes clinical diagnostics offering liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics offers develops, manufactures, and markets complete blood test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; microbiology offers dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; transplant diagnostics products include human leukocyte antigen typing and testing for organ transplant market; and healthcare market channel offers consumables, diagnostic kits and reagents, equipment, instruments, solutions, and services. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

www.thermofisher.com

125,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: TN8.DE

View More

Performance Overview: TN8.DE

Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

TN8.DE
26.90%
S&P 500 (^GSPC)
1.30%

1-Year Return

TN8.DE
33.61%
S&P 500 (^GSPC)
12.48%

3-Year Return

TN8.DE
28.78%
S&P 500 (^GSPC)
48.66%

5-Year Return

TN8.DE
817.37%
S&P 500 (^GSPC)
108.07%

Compare To: TN8.DE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: TN8.DE

View More

Valuation Measures

As of 5/16/2025
  • Market Cap

    138.97B

  • Enterprise Value

    164.20B

  • Trailing P/E

    23.99

  • Forward P/E

    18.25

  • PEG Ratio (5yr expected)

    1.57

  • Price/Sales (ttm)

    3.64

  • Price/Book (mrq)

    3.13

  • Enterprise Value/Revenue

    4.28

  • Enterprise Value/EBITDA

    16.16

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    15.19%

  • Return on Assets (ttm)

    5.00%

  • Return on Equity (ttm)

    13.70%

  • Revenue (ttm)

    42.9B

  • Net Income Avi to Common (ttm)

    6.51B

  • Diluted EPS (ttm)

    15.24

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.95B

  • Total Debt/Equity (mrq)

    69.23%

  • Levered Free Cash Flow (ttm)

    5.77B

Research Analysis: TN8.DE

View More

People Also Watch